FDA oversight : blood safety and the implications of pool sizes in the manufacture of plasma derivatives : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, first session, July 31, 1997.

Author/creator United States
Format Electronic
PublicationWashington : U.S. Government Printing Office, 1998.
Description1 online resource (iii, 427 pages) : illustrations
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo61576
Subjects

Variant title Federal Drug Administration oversight
General noteTitle from title screen (viewed on Oct. 5, 2015).
General note"Serial no. 105-70."
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references.
Issued in other formPrint version: United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources. FDA oversight
Genre/formLegislative hearings.
Technical rpt numberSerial no. 105-70 (United States. Congress. House. Committee on Government Reform and Oversight)
GPO item number1016-C (online)
Govt. docs number Y 4.G 74/7:B 62/5

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available